KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Non-Current Deffered Revenue (2019 - 2021)

Historic Non-Current Deffered Revenue for Hims & Hers Health (HIMS) over the last 3 years, with Q1 2021 value amounting to $384000.0.

  • Hims & Hers Health's Non-Current Deffered Revenue fell 9454.84% to $384000.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $384000.0, marking a year-over-year decrease of 9454.84%. This contributed to the annual value of $381000.0 for FY2020, which is 9459.09% down from last year.
  • Hims & Hers Health's Non-Current Deffered Revenue amounted to $384000.0 in Q1 2021, which was down 9454.84% from $381000.0 recorded in Q4 2020.
  • Hims & Hers Health's 5-year Non-Current Deffered Revenue high stood at $7.0 million for Q3 2019, and its period low was $381000.0 during Q4 2020.
  • For the 3-year period, Hims & Hers Health's Non-Current Deffered Revenue averaged around $5.1 million, with its median value being $7.0 million (2019).
  • Data for Hims & Hers Health's Non-Current Deffered Revenue shows a peak YoY increase of 0.0% (in 2020) and a maximum YoY decrease of 9459.09% (in 2020) over the last 5 years.
  • Over the past 3 years, Hims & Hers Health's Non-Current Deffered Revenue (Quarter) stood at $7.0 million in 2019, then tumbled by 94.59% to $381000.0 in 2020, then rose by 0.79% to $384000.0 in 2021.
  • Its last three reported values are $384000.0 in Q1 2021, $381000.0 for Q4 2020, and $7.0 million during Q3 2020.